Abstract Venous thromboembolism (VTE), including deep-vein thrombosis and pulmonary embolism, is the third most common cause of vascular death worldwide and a major contributor to costly and debilitating non-fatal complications. Despite the changing landscape of risk factors, preventive and diagnostic strategies, risk stratification and therapies, no contemporary global summary of the burden of VTE is available.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Manuel Monreal
Antiphospholipid antibodies and cardiovascular thrombosis
|
By Sina Rashedi, Hannah Leyva Verified, Saman Siddiqui, Syed Abbas Bukhari, Mariana B. Pfeferman, Nathan Watson, Francisco Ujueta, Mehrdad Zarghami, Yogendra Kanthi, David Jimenez, Manuel Monreal, Deborah M. Siegal, Geoffrey D. Barnes, John Eikelboom, Michelle L. O’Donoghue, Christian T. Ruff, Mattia Galli, Brittany Weber, Samuel Z. Goldhaber, Sacha Uljon, Saskia Middeldorp, Renato D. Lopes, David Garcia, David García, Gregory Y. H. Lip, Jean M. Connors, Harlan M. Krumholz, Jason Knight, Giuseppe Lippi, Mitchell S. V. Elkind, Mary Cushman, Karen H Costenbader, Gregory Piazza, Behnood Bikdeli, Bassil Bacare, Jeffery I. Weitz
|
Nature
Verified
Abstract Antiphospholipid antibodies (aPL) are directed against phospholipids and phospholipid-binding proteins. Laboratory assays used to detect aPL include serological tests for aPL against β2-glycoprotein 1, cardiolipin and other molecules, as well as functional assays for lupus anticoagulant. The presence of aPL can lead to endothelial dysfunction or a hypercoagulable state through prothrombotic and antifibrinolytic mechanisms.
Reply to “Comment on: Venous Thromboembolism in Patients Aged ≥ 90 Years: Trends in Clinical Features, Treatment, and Outcomes-RIETE Registry”
We sincerely appreciate the thoughtful comments by Yilmaz Kars et al. [1] in their letter titled “Comment on: venous thromboembolism in patients aged ≥ 90 years: trends in clinical features, treatment, and outcomes—RIETE registry.” Constructive engagement such as this [2] strengthens our collective understanding of managing venous thromboembolism (VTE) in very old adults (a population often excluded from clinical research). Yilmaz Kars et al.
Malta en sus detalles
El Gran Viajero Manuel Monreal traza las pinceladas de un viaje histórico y sentimental de Malta, una isla que ama y conoce como pocos, en un fresco que forma a un recorrido que no podrás dejar de seguir en Tu Gran Viaje a Malta. En Malta los pescadores pintan un ojo en la proa de sus barcos.
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease - Nature Reviews Cardiology
Abstract Balancing the safety and efficacy of antithrombotic agents in patients with gastrointestinal disorders is challenging because of the potential for interference with the absorption of antithrombotic drugs and for an increased risk of bleeding. In this Review, we address considerations for enteral antithrombotic therapy in patients with cardiovascular disease and gastrointestinal comorbidities.
Gozo y Comino, vida serena en Malta
Gozo y Comino no pueden quedar fuera de Tu Gran Viaje a Malta. Islas calmas y serenas donde el tiempo se mece y el Mediterráneo es puro como en ningún otro lugar. Al norte de la Isla de Malta está Gozo, la isla más septentrional del archipiélago, pequeña y con un paisaje suavemente ondulado, con colinas y valles llenos de flores silvestres y plantas de alcaparras, que allí toman acompañadas de tomates secados al sol y de un queso de cabra muy blanco y muy alegre de pimienta.
Siguiendo el camino de los beats en San Francisco
Ginsberg y Coppola, City Lights y la sombra del Sentinel: lugares donde todavía puedes aullar tu talento. Bienvenido a Frisco, la ciudad más beat del planeta. En San Francisco, como en todas las grandes ciudades, hay caminos que se recorren sin saberlo. Uno de ellos está en North Beach, en pleno “Little Italy”, a poco más de un kilómetro del Fisherman’s Wharf, y muy cerca de Chinatown y del Financial District.
Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombi
Behnood Bikdeli, David Jiménez, Alfonso Muriel, Deisy Barrios, Aitor Ballaz, Peter Verhamme, Manuel Monreal the RIETE Investigators European Respiratory Journal 2020 56: 2000538; DOI: 10.1183/13993003.00538-2020 Abstract Right heart thrombi portend worse outcomes in pulmonary embolism (PE). In propensity-matched analyses of patients from a large registry, reperfusion therapy was not associated with significantly reduced odds of all-cause or PE-related mortality.
Pulmonary embolism in Europe remains a cause of concern despite declining deaths
Pulmonary embolism is the most dreaded presentation of venous thromboembolic disease. Because it is managed by interdisciplinary teams, including internists, haematologists, pulmonologists, cardiologists, vascular medicine specialists, vascular surgeons, and generalists, among others, issues can often be overlooked. Furthermore, it has not been addressed in previous reports of cause-specific mortality by the Global Burden of Disease workgroup. This article is available free of charge.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Manuel
Contact Manuel, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack